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The Evaluation of Processes and Indicators in Infection Control (EPIC) study  assesses the relationship
between hospital care and rates of central venous catheter-associated primary bacteremia in 54 intensive-
care units (ICUs) in the United States and 14 other countries. Using ICU rather than the patient as the primary
unit of statistical analysis permits evaluation of factors that vary at the ICU level. The design of EPIC can
serve as a template for studies investigating the relationship between process and event rates across health-
care institutions.
Comparing Clinical Performance
Health-care organizations are increasingly expected to
provide clinical outcomes data as measures of clinical quality
to accrediting bodies, purchasers, and the public, under the
premise that outcome variations indicate quality differences
across organizations. Variation in clinical performance can
result from variation in any number of factors, some relevant
to improving the quality of care but many not. The best-
studied source of variation in clinical performance measures
is patient characteristics. Hospitals differ widely in the
severity of illness and extent of coexisting illnesses in their
patients, and much research has been devoted to developing
risk adjustment methods to permit interhospital comparisons
not confounded by patient characteristics (1). Hospitals also
differ in methods of data abstraction and data management
(2). Even subtle differences in definitions can introduce
measurable variation in clinical performance(3).
Variations in patients, data collection, and definitions
distract from collecting comparative data for quality
improvement. To be useful, an indicator must be linked to
variations in the processes of care provided since these
processes are within the scope of control of the health-care
organization. Furthermore, the “signal” must be separable
from the “noise” of extraneous variation. Despite pressure to
collect and disseminate clinical performance data as
instruments of quality improvement, relatively little research
has been done to establish their validity by demonstrating an
association with process differences between hospitals.
In 1993, the Society for Healthcare Epidemiology of
America (SHEA) responded to a growing concern among its
membership about the sudden increase in the use of clinical
performance comparisons to measure quality of health care.
At the same time, the Joint Commission on Accreditation of
Healthcare Organizations announced a plan to require all
hospitals to collect an identical set of comparative indicators
as part of its Agenda for Change Initiative. In 1994, the Joint
Commission and SHEA formed a collaboration called the
Project to Monitor Indicators (4) to foster the science of
comparative indicators for the benefit of both organizations
and the health-care community. The initial demonstration
project, called the Comparison of Hospital Performance
Indicators, was completed in 1997 (3). The second project,
which is nearing completion, is called Evaluation of Processes
and Indicators in Infection Control (EPIC). EPIC’s area of
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focus is bloodstream infections, specifically those in
intensive-care unit (ICU) patients.
Because hospital epidemiology is a mature discipline,
infection control indicators offer excellent opportunities to
demonstrate how processes of care relate to infectious disease
outcomes. Hospital epidemiology has long addressed surveil-
lance techniques, disease definitions, patient risk factors, and
process factors that may influence disease rates (5-7).
EPIC Study Design
EPIC is two investigations under one name. The first
investigation is designed to answer the following question: do
the relative rankings of hospitals change, with indicators of
bloodstream infection used for comparison? The design is
relatively straightforward. With the assistance of the Centers
for Disease Control and Prevention’s Hospital Infections
Program, the project identified six vendors offering different
bloodstream infection indicators. A sample of 36 hospitals is
collecting the data necessary to calculate these six indicators.
When completed, the relative rankings of the hospitals across
the set of indicators will be compared. The second
investigation is designed to answer the following question:
can variation in hospital care process explain variation in
bloodstream infection rates across a sample of ICUs? The
design for answering this question differs considerably from
traditional epidemiologic designs (e.g., cohort and case-
control designs).
Patient Risk vs. Unit Rates
EPIC relates process performance to variation in
bloodstream infection rates across ICUs. Traditional
epidemiologic designs focus on the prediction of disease risk
for the individual patient. In a traditional cohort study, the
processes of care under scrutiny would be documented in ICU
patients with central venous catheters. Primary bloodstream
infections are relatively rare, even in this vulnerable
population; however, this rarity presents practical problems
in study design. Given an average 3% risk to each patient,
prospective cohorts would have to include approximately
2,500 patients to have 80% power to detect as statistically
significant a twofold relative risk associated with an exposure
common to 25% of ICU patients. The case-control design was
developed to address situations in which the outcome under
study is uncommon; however, case-control studies establish
exposure status after the disease has occurred. Therefore, not
all varieties of exposure can be studied. In hospital
epidemiology, exposures that are reliably documented in the
medical record (coexisting diseases, for example) can be
studied by a case-control approach. However, relevant aspects
of the process of care are not always documented (e.g., the
experience of the central venous catheter inserter or the
number of attempts at insertion) and may be difficult to
establish retrospectively.
Even if all relevant process factors could be documented
in advance, some factors cannot be studied within a single
ICU or even across a small number of ICUs. In many
instances, process exposures are mandated by hospital, ICU,
or infection control policy. In this situation, all patients
within an ICU may have catheters inserted with specific types
of barriers or have a similar skin preparation before catheter
insertion. If there is no variation in the process under study
within an ICU, that process cannot be evaluated by
examining patients within that ICU. One would need to
examine many ICUs with varied processes to relate the
process to disease risk.
Ultimately, traditional designs cannot address the
variation in unit rates because they focus on the wrong unit of
analysis, i.e., the patient rather than the ICU. To study
variation in ICU bloodstream infection rates, the ICU is the
appropriate unit of analysis. The ICU rate is an aggregate
measure that represents the average risk for bloodstream
infection. Strong but infrequent determinants of patient risk
have relatively little influence on the unit rate. A certain
process factor, like gross contamination at the insertion site,
may be related to a marked increase in bloodstream infection
risk for individual patients but may occur so rarely that the
overall rate of infection is not noticeably influenced. Even if a
strong determinant of risk were relatively common, it would
not necessarily be an important determinant of differences in
bloodstream infection rates across ICUs. For an exposure to
affect variation in rates between ICUs, two criteria must be
met. First, the condition must be common enough to influence
the bloodstream infection rate, i.e., it must have a fairly high
attributable risk. Second, there must be variation between
ICUs in the proportion of patients affected. Even a strong
factor will not explain differences if every ICU has the same
proportion of patients affected. Conversely, a relatively
modest determinant of patient risk could account for a
substantial proportion of the variation between ICU infection
rates if ICUs varied greatly in the proportion of patients
exposed. The average patient and average process determine
the ICU infection rate since the ICU rate is a function of the
average patient risk. The difference between individual risk
and population rates has been extensively explored elsewhere
(8).
When the ICU is the unit of analysis, important
difficulties in evaluating process can be resolved. First,
factors that vary at the level of the ICU can be studied
appropriately. Factors not routinely charted can also be
studied efficiently. Since the goal of the evaluation is to relate
the average process to the ICU rate, only data sufficient to
adequately characterize the average process are required.
Therefore, every insertion in an ICU does not have to be
followed; a random sample of insertions allows characteriza-
tion of typical performance. On the other hand, many ICUs
must be studied, since the sample size of the project is not the
number of patients in ICUs but the number of ICUs being
compared.
EPIC Process Assessment Design
In 1998, the membership of SHEA and other interested
persons were solicited to support participation of their
respective hospitals in the study. Initially, 58 hospitals
volunteered to participate (Table) (four were added later and
eight withdrew). Data collection began in November 1998 and
continued through January 2000, and data from 54 ICUs have
been forwarded to the coordinating unit. The number of ICUs
was determined by the willingness of epidemiologists and
infection control personnel to participate in the study.
However, the sample size is sufficient to evaluate important
determinants of variation in ICU bloodstream infection rates.
With a sample of 54 ICUs, a factor that explains 7% of the
variance in the ICU rates would be statistically significant
(alpha=0.05).
Because of its precise definitions and long history of use
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(NNIS) System’s central venous catheter-associated primary
bloodstream infection indicator in ICU patients was used (9).
To establish the rate, each ICU reported all qualifying
infections to the coordinating unit throughout the study
period. Units also reported their central-line days throughout
the study period. Using these data elements, the coordinating
unit calculated the NNIS indicator rate for each hospital.
Data on process and patient characteristics were
collected for a random sample of central venous catheter
insertions in patients admitted to the study ICUs. All
hospitals were provided with the same list of five randomly
selected dates and times each month. The study volunteers
identified the first catheter insertion occurring after each
random date and time and recorded a number of patient and
process factors and interviewed the line inserter to document
details of the insertion. Interviews were conducted within 48
hours of the insertion. It was not necessary for the insertion to
have occurred in the study ICU; any patient who was
admitted to the ICU within 8 hours of central venous catheter
insertion qualified. Up to 65 insertions were documented
during the study in each ICU. Each patient was monitored for
bloodstream infection for 2 days after discharge from the ICU.
The higher the number of insertions assessed, the more
precise the assessment of process. However, the increase in
precision with sample size is not linear. The increase in
precision in the estimate of the mean is a function of the
standard error, which in turn is a function of the inverse of the
square root of the sample size. Therefore, the return from
increasing the sample size by a given amount decreases as the
sample size increases. For example, adding 45 new
observations to an initial sample of 20 observations increases
the relative precision in the estimate of the mean by
approximately 80%. Adding 45 new observations to an initial
sample of 55 increases the precision only by approximately
30%. The value of 65 was selected because it was large enough
to provide acceptably precise performance estimates but was
not so large as to preclude voluntary participation in the
study.
Data elements collected in EPIC are as follows: 1) Factors
related to the patient: age, sex, primary and secondary
diagnoses, length of ICU stay, dialysis, neutropenia, active
treatment for cancer involving either chemotherapy or
radiotherapy, albumin <3 g/L, burns involving >10% of body
surface area, HIV/AIDS, current immunosuppressive therapy,
and surgery under general anesthesia within 2 weeks before
insertion. 2) Factors related to the line: type of central line,
number of lumens, coating with antimicrobial material,
anatomic site of insertion, location of insertion, urgency of
insertion, use of the line for hyperalimentation, line exchange
over a guide wire, and duration of the line. 3) Factors related
to the insertion of the line: use of barrier precautions (sterile
gown, mask, large drape, small drape), type of dressing
applied, time from initial needlestick until line secured,
number of sites attempted before completion, number of
attempts made at the final insertion site, experience of the
inserter (years inserting and number of lines inserted in the
past 6 months), professional background of the inserter, and
unusual occurrences during the insertion. 4) Factors related
to the organization: number and kinds of ICUs within the
hospital, presence of an infection control committee, length of
time tracking bloodstream infection rates, experience
tracking central line-days, NNIS participation, number of
blood cultures done in the previous year, staffing for ICU
surveillance, percentage of lines managed by a team,
percentage of lines using a needleless systems, and number of
in-service training sessions provided to the ICU staff in the
previous 6 months. 5) Factors related to the study ICU:
number of hours devoted to surveillance in the study ICU,
experience and training of the infection control staff doing
surveillance, total of registered nurse hours in the ICU,
number of agency nurse hours used for staffing, number of
“float” nurse hours used for staffing, total number of patient
days, and minimum experience required for a new ICU nurse.
Conclusions
The goal of comparative measurement for quality
improvement is to identify opportunities for improvement by
showing which organizations have superior processes.
However, a clear link between process and indicator needs to
be established before the indicator can be confidently used for
this purpose. The design of EPIC provides an opportunity to
relate the typical care process directly to bloodstream
infection rates in ICUs. Because the ICU is the unit of
analysis, EPIC can evaluate process factors that could not be
addressed by studies within a single ICU, specifically
processes and policies that apply to all patients within an
ICU. In addition, because the sample of patients in each ICU
are followed for the development of bloodstream infections,
the study affords a unique opportunity to compare an analysis
based on patient risk with one based on unit rates.
The coordinating activities of EPIC are supported by a
cooperative agreement with CDC’s Hospital Infections Program
under the Prevention Epicenters Program.
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